Targeted and biological therapies offer potential to reduce disease activity and organ damage in SLE
New targeted and biological therapies show promise for lupus patients
This systematic review identifies 90 targeted agents, including 70 bDMARDs and 20 tsDMARDs, for the treatment of systemic lupus erythematosu…
Newer targeted and biological treatments may help people with lupus reduce disease activity and lower their need for steroids.
Late-onset rheumatoid arthritis shows higher DAS28 scores and lower remission rates compared to young-onset disease in a meta-analysis
Meta-analysis compares treatment outcomes in older versus younger rheumatoid arthritis patients
This meta-analysis reviewed data from over 5000 patients with late-onset rheumatoid arthritis (LORA) and young-onset rheumatoid arthritis (Y…
A large review found older patients with rheumatoid arthritis had higher disease activity and lower remission rates on biologics compared to…